$SG

Sweetgreen (SG) Q2 2026 Earnings Call Transcript

Sweetgreen (SG) reported Q2 2026 revenue of $192.7M, up 4% YoY, driven by 36 net new restaurant openings. Same-store sales fell 6.2%. Restaurant-level margin was 13.1% and adjusted EBITDA was a $0.2M loss. FY2026 guidance was revised for cyclospora impacts, with comparable sales expected to decline 7% to 8% and restaurant margin 10.5% to 11.0%.

Original reporting
Published Aug 14, 2026, 12:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sweetgreen (SG) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SGBearishHigh
01

Why it matters

The cyclospora outbreak and related consumer concern are quantified as a direct headwind to FY2026 comparable sales (200 to 300 bps) and EBITDA ($7M to $10M), prompting guidance revisions across sales, margins, and profitability.

02

Market read

Traders can reprice Sweetgreen’s forward demand and margin trajectory based on the explicit FY2026 guidance cuts and the quantified outbreak/recall risks.

03

What to watch

The company cites potential 150 bps cost savings from waste reduction and reports throughput improvements, which could partially offset the margin hit if execution holds.

Relevance 9/10Novelty 9/10Timing: post-call, pre-positioning for FY2026 guidance and cyclospora headline risk

Background

Sweetgreen is in a transformation plan emphasizing Infinite Kitchen automation, menu mix shifts toward wraps, and throughput/accountability improvements.

Company-level read

Ticker impact

$SGBearishHigh confidence
Context

Sweetgreen reported Q2 revenue of $192.7M, same-store sales down 6.2%, and revised FY2026 guidance due to the cyclospora outbreak.

Expected impact

Bias toward downside or elevated volatility until investors underwrite the cyclospora duration and margin recovery path.

Evidence & confidence

The article discloses multiple forward-looking revisions: FY comparable sales expected to decline 7% to 8% (cyclospora impact), restaurant-level margin guidance cut to 10.5% to 11.0%, and FY adjusted EBITDA revised to a loss of $27M to $23M.

Market effects

Fresh-casual and quick-service peers may face read-across risk if cyclospora headlines continue to suppress produce-driven demand.

No specific regional macro impact beyond New York and Seattle transaction comps returning positive in Q2.

Limited, as the driver is a US-linked public health headline and company-specific recall.

Counterpoint

Digital revenue mix (66.3% total, owned 38.8%) and wrap-driven frequency gains could cushion unit economics if the outbreak fades faster than feared.

Key entities

  • Sweetgreen, Inc.

    Reported Q2 2026 results and revised FY2026 guidance due to cyclospora-related demand disruption and a jalapeño recall.

  • Jonathan Neman

    CEO attributed sales and transaction trends to wraps value positioning and throughput process changes.

  • Jamie McConnell

    CFO quantified cost structure pressures and the cyclospora outbreak impact on guidance.

Related articles

$SGMed

Sweetgreen Stock Jumps After Wells Fargo Upgrade

Sweetgreen (SG) stock rose 6.8% after Wells Fargo upgraded it to overweight with an $11 price target, citing a recovery from a cyclospora outbreak. Analyst Anthony Trainor expects fundamentals to improve and comps to turn positive by FY27. The company's market value had dropped over 25% due to the outbreak, but the stock is up 25% in 2024 and 60% from its August low.

$SGHigh

Why is Sweetgreen stock climbing today?

Sweetgreen (SG) stock rose 2.2% to $8.42 after Wells Fargo upgraded it to Overweight with a $11 price target, citing improved fundamentals and customer traffic recovery. The bank noted potential for high-teens annual unit growth and stabilizing same-store sales. The broader market was down, but Sweetgreen's gains were driven by the upgrade and positive operational outlook.

$SGMed

Sweetgreen (SG) Stock Trades Up, Here Is Why

Sweetgreen (SG) shares rose 4.8% premarket after Wells Fargo upgraded it to overweight, citing improved fundamentals and faster restaurant throughput. The analyst highlighted potential for high-teens annual unit growth and high cash returns on new openings, despite recent volatility and a 25% drop due to a health scare.

$SGHigh

Why is Sweetgreen stock rallying today?

Sweetgreen (SG) stock rose 5.3% in pre-market trading after KeyBanc upgraded it to Overweight with a $9 price target. The firm cited improving sales trends and raised its same-store sales estimates for 2026 and 2027. The stock traded near multi-year lows before the upgrade.